Shanghai Innostar Biotechnology Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Innostar Biotechnology has a total shareholder equity of CN¥1.6B and total debt of CN¥246.5M, which brings its debt-to-equity ratio to 15%. Its total assets and total liabilities are CN¥2.8B and CN¥1.1B respectively. Shanghai Innostar Biotechnology's EBIT is CN¥158.9M making its interest coverage ratio -19.5. It has cash and short-term investments of CN¥1.2B.
Key information
15.0%
Debt to equity ratio
CN¥246.50m
Debt
| Interest coverage ratio | -19.5x |
| Cash | CN¥1.16b |
| Equity | CN¥1.64b |
| Total liabilities | CN¥1.14b |
| Total assets | CN¥2.78b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688710's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥881.3M).
Long Term Liabilities: 688710's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥254.6M).
Debt to Equity History and Analysis
Debt Level: 688710 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 688710's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 688710's debt is well covered by operating cash flow (35.4%).
Interest Coverage: 688710 earns more interest than it pays, so coverage of interest payments is not a concern.